Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2004
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas
Chih-Yi Hsu, Robert Bristow, Moon Seok Cha, et al.
Radiation Oncology (London, England)
|
November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improve
Jarad M Martin, Andrew Bayley, Robert Bristow, et al.
Cancers
|
December 11, 2022
T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC)
Luca G Campana, Wasat Mansoor, James Hill, et al.
Cancer Research
|
July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response
Michael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy
Danny Vesprini, Michael Sia, Gina Lockwood, et al.
The Journal of Experimental Medicine
|
April 14, 2010
Rnf8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer
Li Li, Marie-Jo Halaby, Anne Hakem, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2014
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors
Monica Mita, Michael Gordon, Lee Rosen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma
Jarad M Martin, Tara Rosewall, Andrew Bayley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2025
Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis
Ji Hyun Kim, Myong Cheol Lim, Eun Taeg Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2012
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer
Michael Milosevic, Padraig Warde, Cynthia Ménard, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2004
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas
Chih-Yi Hsu, Robert Bristow, Moon Seok Cha, et al.
Radiation Oncology (London, England)
|
November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improve
Jarad M Martin, Andrew Bayley, Robert Bristow, et al.
Cancers
|
December 11, 2022
T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC)
Luca G Campana, Wasat Mansoor, James Hill, et al.
Cancer Research
|
July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response
Michael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy
Danny Vesprini, Michael Sia, Gina Lockwood, et al.
The Journal of Experimental Medicine
|
April 14, 2010
Rnf8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer
Li Li, Marie-Jo Halaby, Anne Hakem, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2014
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors
Monica Mita, Michael Gordon, Lee Rosen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma
Jarad M Martin, Tara Rosewall, Andrew Bayley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2025
Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis
Ji Hyun Kim, Myong Cheol Lim, Eun Taeg Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2012
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer
Michael Milosevic, Padraig Warde, Cynthia Ménard, et al.
Page
of 6